Last updated on April 2019

Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of Canagliflozin (TA-7284) in Japanese patients with Diabetic Nephropathy, compared with placebo

Clinical Study Identifier: NCT03436693

Find a site near you

Start Over

Research site

Fukuoka, Japan
5.61miles
  Connect »